Form 8-K - Current report:
SEC Accession No. 0001079973-25-000912
Filing Date
2025-05-20
Accepted
2025-05-20 17:07:29
Documents
14
Period of Report
2025-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 29184
2 PROMISSORY NOTE ex4x1.htm EX-4.1 37228
3 PERSONAL GUARANTY ex10x1.htm EX-10.1 11283
  Complete submission text file 0001079973-25-000912.txt   253653

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE scpx-20250515.xsd EX-101.SCH 3099
5 XBRL LABEL FILE scpx-20250515_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE scpx-20250515_pre.xml EX-101.PRE 22376
16 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 3359
Mailing Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 25969831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)